Series A

American Lithium Minerals acquires a high-grade gold claim in BC's Golden Triangle while pivoting to a revolutionary but risky blockchain financing model.

Slingshot Aerospace's TALOS AI will create unpredictable, machine-speed adversaries, revolutionizing how Guardians prepare for orbital conflict.

Four startups won the UAE FoodTech Challenge, sharing $2M to scale their solutions for food production and waste reduction from the UAE to the Global South.

As Moelis & Co. prepares to report its 2025 results, investors are watching to see if the firm capitalized on a record year for dealmaking.

With a promising brain injury drug and no approved rivals, Oragenics heads to a tax-haven investor summit to secure funding for its next critical phase.

The U.S. Army partners with Velo3D, using advanced 3D printing to create mission-critical metal parts and bolster the readiness of its combat fleet.

The investment firm celebrated a strong 2025 with shareholder payouts, fueled by profitable exits and a new major investment in AI infrastructure firm TensorWave.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

Hong Kong's 3E Network completes a $2M financing round, fueling its strategic shift into the competitive global AI infrastructure market.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

With a key FDA decision looming, Orca Bio's massive new funding aims to commercialize a therapy that could make curative transplants safer for more patients.

After its stock soared on a Starlink deal, private jet operator flyExclusive announced a public offering, balancing growth ambitions with market risk.

The biotech firm launches an early access program for its novel platform, starting with a tau assay that could revolutionize Alzheimer's research.

A new vectorized antibody therapy for ALS, VTx-002, has been granted FDA Fast Track status, accelerating its path to patients battling the disease.

Defense tech startup Vatn Systems acquires Crewless Marine, a strategic move to vertically integrate key sensor technology and accelerate its rise in naval warfare.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

With a top neurologist at the helm and a breakthrough platform, NanoMosaic aims to decentralize brain health diagnostics and reshape drug development.

TwelveStone Health Partners and AI firm Tennr are teaming up to automate patient referrals, aiming to slash wait times and improve access to vital care.

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?